Utility of significant number of mesothelial cells in tuberculous pleural effusions

I. Djordjevic, M. Radovic, S. Golubovic, D. Dacic, T. Pejcic, J. Gligorijevic (Nis, Serbia & Montenegro)

Source: Annual Congress 2004 - Diagnosis of tuberculosis
Session: Diagnosis of tuberculosis
Session type: Thematic Poster Session
Number: 2626
Disease area: Respiratory infections, Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Djordjevic, M. Radovic, S. Golubovic, D. Dacic, T. Pejcic, J. Gligorijevic (Nis, Serbia & Montenegro). Utility of significant number of mesothelial cells in tuberculous pleural effusions. Eur Respir J 2004; 24: Suppl. 48, 2626

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Correlation between pleural fluid cytological yield and pleural tumour burden in malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010


Cytology of pleural fluid versus histopathology of the pleura in the diagnosis of malignant pleural effusions
Source: Eur Respir J 2006; 28: Suppl. 50, 775s
Year: 2006

Diagnostic value of combined assays in differentiating tuberculous and malignant pleural effusions
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008


Accuracy of pleural fluid c-reactive protein in differentiating between tuberculous and malignant pleural effusions: a meta-analysis
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019

Significance of macrophage predominance in pleural effusions
Source: Annual Congress 2003 - Pleural effusion
Year: 2003


Incidence and aetiology of eosinophilic pleural effusion
Source: Eur Respir J 2009; 34: 1111-1117
Year: 2009



Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma
Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions
Year: 2012

Is ²blind² pleural biopsy still of value in tuberculous effusions?
Source: Annual Congress 2008 - Diagnosis of tuberculosis: problems and perspectives
Year: 2008

Transudative malignant pleural effusions
Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice?
Year: 2019



LSC Abstract – A requirement for mast cells in malignant pleural effusion
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015

Mast cells recruitment to malignant pleural effusions
Source: Annual Congress 2010 - Current issues in malignant pleural diseases
Year: 2010


Utility of pleural fluid for predictive marker testing in malignant pleural effusion
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Year: 2020



Prognostic features of residual pleural thickening after parapneumonic pleural effusion
Source: Eur Respir J 2002; 20: Suppl. 38, 605s
Year: 2002

Diagnostic approach in a patient with pleural effusion
Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=131
Year: 2002

Management of malignant pleural effusions
Source: ERS Skills course: Multi-disciplinary care in thoracic oncology
Year: 2019

Management of malignant pleural effusions
Source: Guideline 2001
Year: 2001

Management of malignant pleural effusions
Source: Eur Respir J 2001; 18: 402-419
Year: 2001


Closed pleural brushing in the diagnosis of malignant pleural effusions
Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases
Year: 2008